Nu Skin Enterprises Files 2024 10-K

TL;DR

NU SKIN 10-K FILED: FY24 RESULTS IN, DEBT PAYMENTS SPREAD OUT OVER 5 YRS.

AI Summary

Nu Skin Enterprises, Inc. filed its 2024 10-K on February 14, 2025, reporting on its fiscal year ending December 31, 2024. The filing details the company's financial performance and business operations. Key financial data includes noncurrent other assets of $25.6 million and current accrued liabilities of $13.5 million. A significant portion of debt, 21%, is structured to be paid in increasing quarterly installments over a five-year period starting September 30, 2022.

Why It Matters

This 10-K filing provides investors with a comprehensive overview of Nu Skin's financial health and strategic positioning for the fiscal year 2024, impacting investment decisions.

Risk Assessment

Risk Level: medium — The company has a significant portion of its debt payable over a five-year period, which could indicate financial leverage or a need for ongoing cash flow management.

Key Numbers

• $25.6M — Other Assets (Noncurrent) (Represents long-term assets not classified elsewhere.)
• $13.5M — Accrued Liabilities (Current) (Represents short-term obligations incurred but not yet paid.)
• 21% — Debt Payable in Installments (Indicates a structured debt repayment plan over five years.)

Key Players & Entities

• NU SKIN ENTERPRISES, INC. (company) — Filer of the 10-K
• February 14, 2025 (date) — Filing date of the 10-K
• December 31, 2024 (date) — Fiscal year end
• GREGORY BELLISTON (person) — Contact person for business and mail address
• $25.6 million (dollar_amount) — Noncurrent other assets
• $13.5 million (dollar_amount) — Current accrued liabilities
• September 30, 2022 (date) — Start date of debt repayment period

FAQ

From the Filing

0001140361-25-004907.txt : 20250214 0001140361-25-004907.hdr.sgml : 20250214 20250214172338 ACCESSION NUMBER: 0001140361-25-004907 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 137 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250214 DATE AS OF CHANGE: 20250214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NU SKIN ENTERPRISES, INC. CENTRAL INDEX KEY: 0001021561 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 870565309 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12421 FILM NUMBER: 25631086 BUSINESS ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 BUSINESS PHONE: 801-345-1000 MAIL ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ENTERPRISES INC DATE OF NAME CHANGE: 19980909 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ASIA PACIFIC INC DATE OF NAME CHANGE: 19960919 10-K 1 ef20039018_10k.htm FORM 10-K false 12-31 2024 FY 0001021561 25600000 13500000 http://fasb.org/us-gaap/2024#UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#RestructuringCostsAndAssetImpairmentCharges http://fasb.org/us-gaap/2024#RestructuringCostsAndAssetImpairmentCharges Variable 30 day: 6.71% Variable 30 day: 6.71% 21% of the principal amount is payable in increasing quarterly installments over a five-year period that began on September 30, 2022, with the remainder payable at the end of the five-year term http://fasb.org/us-gaap/2024#RestructuringCostsAndAssetImpairmentCharges true 238 2025-12-31 2044-12-31 2028-12-31 2034-12-31 0001021561 2024-01-01 2024-12-31 0001021561 2024-06-28 0001021561 2025-01-31 0001021561 2023-12-31 0001021561 2024-12-31 0001021561 2022-01-01 2022-12-31 0001021561 2023-01-01 2023-12-31 0001021561 us-gaap:RetainedEarningsMember 2021-12-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001021561 2021-12-31 0001021561 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001021561 us-gaap:TreasuryStockCommonMember 2021-12-31 0001021561 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-01-01 2022-12-31 0001021561 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001021561 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-12-31 0001021561 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0001021561 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-12-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0001021561 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001021561 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0001021561 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-12-31 0001021561 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001021561 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001021561 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001021561 us-gaap:RetainedEarningsMember 2024-12-31 0001021561 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-12-31 0001021561 us-gaap:AccumulatedOtherComprehensiveI